United Guardian (UG) Cash from Operations (2010 - 2026)
United Guardian's (UG) quarterly Cash from Operations came in at $1.5 million in Q2 2026, up 401.25% year-over-year from $303243.0 in Q2 2025, and up 151.43% quarter-over-quarter from $604536.0 in Q1 2026.
Analysis
United Guardian (UG) Cash from Operations (2010 - 2026) Analysis & Trends
United Guardian has disclosed Cash from Operations across 17 years of filings, most recently posting $1.5 million for Q2 2026.
- In Q2 2026, Cash from Operations rose 401.25% year-over-year to $1.5 million; the TTM figure through Jun 2026 stood at $3.5 million (up 63.24% YoY), while the FY2025 annual figure was $2.0 million, down 43.26% from the prior year.
- Cash from Operations came in at $1.5 million for Q2 2026 at United Guardian, up from $604536.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of $1.5 million in Q2 2026 to a low of $27415.0 in Q1 2022.
- Average Cash from Operations over 5 years is $734847.2, with a median of $634416.5 recorded in 2022.
- Year-over-year, Cash from Operations slumped 97.23% in 2022 and soared 1423.21% in 2023.
- Over 5 years, Cash from Operations stood at $624713.0 in 2022, then jumped by 80.49% to $1.1 million in 2023, then slumped by 76.12% to $269297.0 in 2024, then gained by 22.73% to $330495.0 in 2025, then jumped by 359.91% to $1.5 million in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were $1.5 million in Q2 2026, $604536.0 in Q1 2026, and $330495.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.54 Bn | 626.78 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 441.45 Bn | 434.88 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 364.78 Bn | 357.64 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 267.01 Bn | 259.32 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn | 835.00 Mn |
| 6 | Sanofi | 52.54 Bn | 45.16 Bn | 10.79 Bn | 3.44 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | -387.32 Mn |
| 8 | Incyte | 25.36 Bn | 20.82 Bn | 1.57 Bn | 507.66 Mn |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn | 313.60 Mn |
| 10 | United Guardian | 32.95 Mn | 23.36 Mn | 1.55 Mn | 1.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.52 Mn |
| Mar 31, 2026 | 604,536.00 |
| Dec 31, 2025 | 330,495.00 |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 303,243.00 |
| Mar 31, 2025 | 322,080.00 |
| Dec 31, 2024 | 269,297.00 |
| Sep 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | 1.32 Mn |
| Mar 31, 2024 | 644,120.00 |
| Dec 31, 2023 | 1.13 Mn |
| Sep 30, 2023 | 1.16 Mn |
| Jun 30, 2023 | 434,658.00 |
| Mar 31, 2023 | 417,589.00 |
| Dec 31, 2022 | 624,713.00 |
| Sep 30, 2022 | 735,855.00 |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 27,415.00 |
| Dec 31, 2021 | 1.66 Mn |
| Sep 30, 2021 | 1.03 Mn |